NANA KANZAVELI: Open Payments
NPI 1396960761 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 31 payments from 12 companies in 2025. Trend: 2023 $808 · 2024 $730 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 4 | $175 |
| Incyte Corporation | 5 | $117 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $96 |
| Amgen Inc. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $59 |
| Biofrontera Inc. | 3 | $57 |
| LNHC, Inc | 2 | $40 |
| GENZYME CORPORATION | 1 | $32 |
| UCB, Inc. | 1 | $26 |
Products named: ANZUPGO, OPZELURA, ILUMYA, OTEZLA, COSENTYX, Sotyktu, ZELSUVMI, Rhapsido.
Industry payments across NY — which companies pay providers there.
